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Abstract
 
Primary 
 
Klebsiella pneumoniae
 
 liver abscess complicated with metastatic meningitis or endophthalmi-
tis is a globally emerging infectious disease. Its pathogenic mechanism remains unclear. The
bacterial virulence factors were explored by comparing clinical isolates. Differences in muco-
viscosity were observed between strains that caused primary liver abscess (invasive) and those
that did not (noninvasive). Hypermucoviscosity correlated with a high serum resistance and
was more prevalent in invasive strains (52/53 vs. 9/52; P 
 
 
 
 0.0001). Transposon mutagenesis
identified candidate virulence genes. A novel 1.2-kb locus, 
 
magA
 
, which encoded a 43-kD
outer membrane protein, was significantly more prevalent in invasive strains (52/53 vs. 14/52;
P 
 
 
 
 0.0001). The wild-type strain produced a mucoviscous exopolysaccharide web, actively
proliferated in nonimmune human serum, resisted phagocytosis, and caused liver microabscess
and meningitis in mice. However, 
 
magA
 
 
 
 mutants lost the exopolysaccharide web and became
extremely serum sensitive, phagocytosis susceptible, and avirulent to mice. Virulence was
restored by complementation using a 
 
magA
 
-containing plasmid. We conclude that 
 
magA
 
 fits
molecular Koch’s postulates as a virulence gene. Thus, this locus can be used as a marker for
the rapid diagnosis and for tracing the source of this emerging infectious disease.
Key words: pathogenesis • serum resistance • virulence • genes • liver abscess • 
meningitis • endophthalmitis
 
Introduction
 
Klebsiella pneumoniae
 
 is an enteric gram-negative bacillus (1,
2) causing hospital-acquired infections (1–3) and infections
in debilitated or immunocompromised patients (1–3). In
the past 15 yr, a new type of invasive 
 
K. pneumoniae
 
 disease
has emerged in Taiwan (4–10) that typically presents a
community-acquired primary liver abscess with sepsis and
bacteremia (4, 5). Metastatic meningitis or endophthalmitis
complicated the course in 10–12% of cases (6–9). Approxi-
mately 50% of the reported patients had diabetes mellitus
(4–10), with the remainder displaying no apparent underlying
diseases. The responsible 
 
K. pneumoniae
 
 strains were uniformly
susceptible to all cephalosporins and aminoglycosides (5,
10). Nevertheless, mortality rates as high as 10% for primary
liver abscess (4–9) and 30–40% among those with meta-
static meningitis have been reported (11, 12). In addition to
being particularly common in Taiwan (4), where 
 
 
 
900
cases have been reported (4–10), this invasive 
 
K. pneumoniae
 
disease has also been reported in North America (13, 14),
Europe (15–19), and Japan (20, 21).
The mechanism of this new infectious disease remains
unclear. Identification of the specific bacterial virulence
factors would help spur the development of rapid molecular
diagnosis methods and innovative drug therapies. Previous
molecular epidemiology analyses (6, 10) have highlighted
the genetic diversity among the involved 
 
K
 
. 
 
pneumoniae
 
strains, indicating that this disease is not caused by one or a
few epidemic strains.
To identify factors that are unique, and so presumably
vital to the virulence process, we compared strains causing
primary liver abscess with strains not associated with liver
abscess.
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Materials and Methods
 
Bacterial Strains and Culture Conditions.
 
Clinical 
 
K. pneumoniae
 
strains isolated from patients with septicemia were collected at
National Taiwan University Hospital (NTUH) from 1996 to
2001. Identification of the isolates was according to standard clin-
ical microbiologic methods (1). All strains were stored at 
 
 
 
80
 
 
 
C
before use.
Among the total of 1,352 isolates obtained from patients with
septicemia, 101 strains were obtained from patients displaying
primary liver abscess. The diagnosis of primary liver abscess was
confirmed by sonography-guided aspiration or surgical drainage
in 53 of these 101 patients. Of these 53 patients, 26 had diabetes
mellitus, 25 were otherwise healthy before development of the
abscess, one patient had nephrotic syndrome, and one patient dis-
played hepatic failure associated with advanced liver cirrhosis.
The strains isolated from the 53 patients were designated as tis-
sue-invasive (invasive) strains. In addition to displaying primary
liver abscesses, four patients displayed metastatic endophthalmitis,
whereas another displayed metastatic meningitis.
Of the remaining 1,251 patients who did not display clinical
symptoms of liver abscess, meningitis, or endophthalmitis, 52 pa-
tients were confirmed to be free of abscess by either abdominal
sonography or computed tomography. The 
 
K. pneumoniae
 
 strains
from these patients were designated as nontissue invasive (nonin-
vasive) strains.
For comparative purposes, we obtained 21 nonblood isolates
from nonseptic patients at NTUH, and 101 strains from other facil-
ities. These included 15 strains (6 of which were found capable of
causing primary liver abscess) were obtained from the National
Cheng Kung University Hospital (NCKUH; a gift from I.-J. Su,
National Health Research Institute, Taipei, Taiwan). Another 13
strains (1 of which caused meningitis without liver abscess and 1 that
caused abscess) were a gift from S.-S. Wang (ECK Hospital, Sansia,
Taiwan). 34 strains, all of which caused nosocomial infections with-
out liver abscess, meningitis, or endophthalmitis, were a gift from
J.-T. Wang (Far Eastern Memorial Hospital, Banciao, Taiwan). 15
strains from Hong Kong were a gift from L.K. Siu (National Health
Research Institute, Taipei, Taiwan). Finally, 24 strains, none of
which caused liver abscess, were purchased from the American
Type Culture Collection, including strain MGH-78578, which
caused pneumonia and was selected for genome sequencing.
For general use, both 
 
K. pneumoniae
 
 and 
 
Escherichia coli
 
 were
grown in Luria-Bertani (LB) broth or agar at 37
 
 
 
C. When neces-
sary, 50 
 
 
 
g/ml of either kanamycin or chloramphenicol was added.
 
String Test for Hypermucoviscosity.
 
The tested strains were inoc-
ulated on 5% sheep blood agar plates and incubated at 37
 
 
 
C over-
night. A standard bacteriologic loop was used to stretch a mucovis-
cous string from the colony. Hypermucoviscosity (HV) was defined
by the formation of viscous strings 
 
 
 
5 mm in length when a loop
was used to stretch the colony on agar plate (positive string test).
 
Serum Resistance Assay.
 
The serum resistance of 
 
K. pneumo-
niae
 
 strains was determined by an established method (22). An in-
oculum of 2.5 
 
  
 
10
 
4
 
 CFU, prepared from the mid-log phase,
was mixed at a 1:3 vol/vol ratio with nonimmune human serum
donated by healthy volunteers. The final mixture was comprised
of 75% nonimmune serum by volume. The mixture was incu-
bated at 37
 
 
 
C. The colony count, determined by the serial dilu-
tion method, was checked at the baseline, and at 1, 2, and 3 h.
The average survival percentage was plotted against the time to
obtain a survival curve that characterized the serum susceptibility.
 
Phagocytosis Assay.
 
The phagocytosis assay of 
 
K. pneumoniae
 
strains was performed by an established method (23). An inocu-
lum of 10
 
7
 
 CFU was mixed with 10
 
6
 
 freshly isolated human neu-
trophils or mouse macrophage cell line RAW-264.7 in RPMI
1640 media (23). After 15 min of incubation, extracellular bacte-
ria were washed out, and 100 
 
 
 
g/ml gentamicin was added to
kill any remaining extracellular bacteria. Cell-associated bacteria
were quantified at zero and 30 min after the end of incubation by
plating on LB agar plates after lysis of the cells with 0.1% Triton
X-100. Initial experiments established that the 
 
magA
 
 knockout
mutants were no more sensitive to the detergent than the wild
type. To determine whether cell-associated bacteria counted by
the aforementioned method were indeed ingested by human
neutrophils, fluorescence microscopy using confocal microscope
was performed. Before fluorescence microscopy, plasmid GFPuv
(CLONTECH Laboratories Inc.), which carries a gene that en-
codes green fluorescent protein, was electroporated into selected
 
K. pneumoniae
 
 strains.
 
Complement C3 Deposition Assay.
 
Complement C3 deposi-
tion assay was performed by an established method (24). A bacte-
rial suspension (2 
 
 
 
 10
 
8
 
 CFU/ml) was opsonized with 25% se-
rum at 37
 
 
 
C for 1–5 min. Bacteria were washed three times with
PBS by pelleting and resuspended. The final pellet was resus-
pended in 50 mM carbonate-bicarbonate buffer, pH 9.0, con-
taining 1 M NH
 
4
 
OH, to disrupt ester bonds between C3 frag-
ments and the bacterial surface. After 2 h at 37
 
 
 
C, the C3
fragment suspension was reduced with 10 mM dithiothreitol in
1% SDS at 37
 
 
 
C for 1 h and alkylated with 22 mM iodoacet-
amide at 37
 
 
 
C for 1 h. Western blot analysis was performed. Dur-
ing the procedure, membranes were incubated sequentially with
anti–human complement C3 (1:2,000; Biogenesis) and goat
horseradish peroxidase–conjugated anti–human IgG antibodies,
before development with an enhanced chemiluminescence sys-
tem (Amersham Biosciences).
 
Animal Inoculation.
 
Female BALB/cByl 6-wk-old mice were
used for inoculation. 
 
K. pneumoniae
 
 inocula consisting of 10
 
2
 
–10
 
6
 
mid-logarithmic growth phase CFUs were diluted in 100 
 
 
 
l nor-
mal saline and injected intraperitoneally (25, 26). Four mice were
used to test the effects of each inoculum. After inoculation, the
mice were observed for 30 d. The LD
 
50
 
 was calculated using the
method established by Reed and Muench (26).
 
Mini-Tn5 Transposon Mutagenesis.
 
A mini-Tn5 transposon
was used for random transposon mutagenesis (27, 28). 
 
E. coli
 
S17–1
 
 
 
pir, which carries the F plasmid and mini-Tn5 transposon
on pUTKm1 plasmid, served as the donor. The conjugation be-
tween wild-type 
 
K. pneumoniae
 
 NTUH-K2044 and 
 
E. coli
 
 S17–
1
 
 
 
pir was facilitated by mechanical force generated by vacuum
suction. During the conjugation, the mini-Tn5 transposon was
transposed into the NTUH-K2044 genome randomly. After in-
sertion, the transposase was lost, thus ensuring the genetic stabil-
ity of generated mutants. 5 
 
 
 
g/ml chlorhexidine was added to
kanamycin-containing LB broth to select for the chlorhexidine-
resistant 
 
K. pneumoniae
 
 NTUHK-2044 oversensitive donor 
 
E. coli
 
S17–1
 
 
 
pir (29). The mutants were harvested and stored at
 
 
 
80
 
 
 
C before use.
 
Inverse PCR and DNA Sequencing.
 
DNA sequences adjacent
to the transposon insertion sites were determined by inverse PCR
and DNA sequencing. The genomic DNA of mutants was ex-
tracted and subjected to complete digestion by restriction endo-
nuclease PstI (2 U of enzyme for 2.0 
 
 
 
g genomic DNA at 37
 
 
 
C
overnight) followed by circularization. Inverse PCR was
performed using the following primers: 5
 
 
 
-GTACCGAGCTC-
GAATTCGGC-3
 
 
 
 and 5
 
 
 
-ATGAGCCATATTCAACGGGA-
3
 
 
 
. DNA sequencing was performed using the BigDye™ Termi-
nator Cycle Sequencing Ready Reaction Kit (PerkinElmer and 
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Applied Biosystems) on an ABI PRISM 377 DNA Sequencer.
Primers 5
 
 
 
-GTACCGAGCTCGAATTCGGC-3
 
 
 
 were used for
sequencing of the inverse PCR products. The obtained se-
quences were further used in designing primers for the sequenc-
ing of the entire nearby region on the genome.
 
Dot-Blot Hybridization and PCR.
 
Standard procedure for dot-
blot hybridization was used (30). For each strain, 100 ng of extracted
genomic DNA was used. The nucleotide probe for 
 
magA
 
, corre-
sponding from 
 
 
 
10 to 
 
 
 
855, was prepared by PCR amplification
followed by photolabeling using a psoralen–biotin system (Ambion).
Hybridization was performed at 63
 
 
 
C overnight. After hybridiza-
tion, the membrane was washed with 2 
 
  
 
SSC plus 0.1% SDS at
room temperature for 10 min, washed 3 
 
  
 
15 min with 0.1 
 
  
 
SSC
plus 0.1% SDS in 58
 
 
 
C, followed by 2 
 
  
 
5–min treatments with
wash buffer (Ambion) at room temperature. Detection was con-
ducted using a chemiluminescence system (Ambion) based on
streptavidin and alkaline phosphatase. Two primer pairs derived
from 
 
magA
 
 were as follows: outer, forward, 5
 
 
 
-GGTGCTCTTTA-
CATCATTGC-3
 
 
 
, and reverse, 5
 
 
 
-GCAATGGCCATTTGCGT-
TAG-3
 
 
 
; and inner, forward, 5
 
 
 
-CGCCGCAAATACGAGA-
AGTG-3
 
 
 
, and reverse, 5
 
 
 
-GCAATCGAAGTGAAGAGTGC-3
 
 
 
.
These were used for nested PCR to detect the presence of 
 
magA
 
.
Ribosomal RNA gene was used as internal positive control for both
dot-blot hybridization and PCR.
 
Complementation and Deletion Clones Construct.
 
The gene
 
magA
 
 and its predicted promoter region were inserted into plas-
mid pCRII
 
®
 
 (Invitrogen) by Taq-amplified cloning. A chloram-
phenicol resistance gene (31) was inserted as the selection marker.
The constructed plasmid was sent into 
 
magA
 
 
 
 mutant by elec-
troporation (29, 32, 33). Deletion clones were constructed by
sending plasmids carrying PCR- or inverse PCR–generated mu-
tated 
 
magA
 
, with various types of deletion, into 
 
magA
 
 
 
 mutants.
All deletion constructs were confirmed by DNA sequencing.
 
Cell Fractionation Procedure and Western Blot.
 
Cell fraction-
ation was performed following a published protocol (34). The 
 
K.
pneumoniae
 
 cells were harvested by centrifugation at 11,000 
 
g
 
 for
20 min. The pellet was resuspended in water, and the cells were
lysed by sonication. Unlysed cells were removed by centrifuga-
tion at 250 
 
g for 5 min. The supernatant was collected and centri-
fuged at 11,000 g for 30 min. The pellet was resuspended in 25  l
PBS by vigorous pipetting, 25  l of 4% Triton X-100 in PBS was
added, and the mixture was incubated at 37 C for 30 min. Triton
X-100–insoluble proteins (outer membrane protein-enriched
fraction) were pelleted by centrifugation at 11,000 g for 30 min.
The supernatant containing Triton X-100–soluble proteins (cyto-
plasmic membrane protein-enriched fraction) was also collected.
Anti-MagA antibodies for Western blot were prepared by inocu-
lating rabbits with a truncated MagA protein (amino acids 44–
221) expressed in E. coli. During the procedure, membranes were
incubated sequentially with anti-MagA antibodies and goat horse-
radish peroxidase–conjugated anti–rabbit IgG antibodies before
development with an enhanced chemiluminescence system (Am-
ersham Biosciences). Spheroplast preparation was performed as
described previously (35). An antibody to NlpB in Serratia marce-
scens (a gift from H.C. Lai, National Taiwan University, Taipei,
Taiwan), which has been shown to be an outer membrane pro-
tein in E. coli (36), was also used as a cell fractionation control.
Results
HV and Clinical Diseases. Differences in the HV phe-
notype (formation of viscous strings  5 mm in length; Fig.
1 A shows a positive string test) were observed between 53
invasive strains and 52 noninvasive strains. In an experi-
ment to test the reproducibility of these results, two inde-
pendent blind readings of 50 clinical isolates yielded a con-
sistency of 98%. The HV phenotype was identified in 52
out of 53 invasive strains (98%), but only in 9 out of 52
noninvasive strains (17%). The difference was highly signif-
icant (P   0.0001; Fisher’s exact test).
Virulence Assay In Vitro and In Vivo. Three  K. pneumo-
niae strains were selected for use in serum resistance assays
and in vivo effect in mice. One was an invasive, HV phe-
notypic strain NTUH-K2044, isolated from the blood of a
previously healthy 40-yr-old man suffering from commu-
nity-acquired primary liver abscess and metastatic meningi-
tis. The second was a noninvasive, non-HV phenotypic
clinical strain NTUH-K9, and the third was the non-HV
phenotypic strain MGH-78578.
The serum resistance assay showed that NTUH-K2044
was not only resistant to serum killing but actually actively
proliferated in nonimmune human serum. In contrast,
MGH-78578 was much less resistant to serum, and NTUH-
K9 was extremely sensitive to serum (Fig. 2 A). This high
serum resistance also correlated with HV phenotype in an-
other eight randomly selected clinical strains, including four
HV  invasive strains and four non-HV noninvasive strains.
The LD50 of NTUH-K2044 to BALB/cByl mice was  102
CFU. Intraperitoneal inoculation of 106 CFU in these mice
resulted in rapid death in 12 h, without definite histopathol-
ogy change. However, inoculation of 102–105 CFU resulted
in death after 1 wk with meningitis and liver microabscess
(Fig. 3, A and B). In contrast, inoculation of NTUH-K9 or
MGH-78578 did not cause death, meningitis, or liver mi-
Figure 1. HV phenotype. (A)
Demonstration of a positive string
test; formation of a viscous string
 0.5 cm in length stretched by
the inoculation loop. (B) Under
light microscopy, wild-type strain
NTUH-K2044 produces an exo-
polysaccharide web attached to the
capsule (Periodic Acid Schiff stain;
original magnification, 1,000).
(C)  magA  mutant loses the
capability of producing an exo-
polysaccharide web.magA Gene in K. pneumoniae Causing Liver Abscess 700
croabscess in mice (Fig. 3, C and D) at any doses (102–106
CFU). The animal experiments were repeated by different
investigators and the results were reproducible.
Loci Associated with HV. To identify genetic loci associ-
ated with the HV phenotype, a mutant library of NTUH-
K2044 was constructed using mini-Tn5 transposon muta-
genesis. A total of 2,500 mutants were obtained. Southern
blot hybridization and DNA sequencing (not depicted)
in randomly selected mutants confirmed random transpo-
son insertions. After screening all the mutants, it was deter-
mined that 20 had lost the HV phenotype. Among these
mutants, mutants 1–11 were identified by their grossly
nonmucoid colony appearance, whereas mutants 12–20
were identified by their presentation of a negative string
test. All 20 mutants exhibited a marked decrease in serum
resistance compared with the wild type (Fig. 2 A). By in-
verse PCR and DNA sequencing, the 20 loci were com-
pletely identified. The loci included K. pneumoniae cps (cap-
sular polysaccharides) cluster (37), wb (lipopolysaccharide)
cluster (38), rmpA (extracapsular polysaccharides synthesis
regulator; references 39, 40), as well as four novel genetic
loci (Table I).
Higher Prevalence of magA in Invasive Strains. Genomic
DNA were extracted from 53 invasive strains and 52 non-
invasive strains. Dot-blot DNA hybridizations were per-
formed using labeled PCR products of each locus as
probes. We found only a novel 1.2-kb locus was signifi-
cantly more prevalent in invasive strains, whereas the other
six genetic loci were universally present in all tested strains.
The novel locus was hit in both mutants 13 and 18 (trans-
poson inserted in nucleotide  70 and  965, respectively).
This locus, designated as magA (mucoviscosity-associated
gene A), was present in 52 out of 53 invasive strains (98%;
the sole strain negative for magA was from the patient with
Figure 2. Serum and phagocytosis
resistance assays. (A) Difference in
serum resistance between NTUH-
K2044, MGH-78578, NTUH-K9,
and mutants 1–20. The assays were
performed sequentially three times.
A high degree of consistency was
observed between experiments. (B)
Restoration of serum resistance by
magA complementation in a magA 
mutant, in comparison with magA 
mutant, magA  mutant–carrying vec-
tor only, wild-type–carrying vector
only, and wild type. (C) Western
blot analysis of complement C3 dep-
osition showing that magA  mutant
(lanes 2 and 5) and cps  mutant
(lanes 3 and 6) have much higher
levels of complement C3 deposition
than the wild type (lanes 1 and 4).
1-min exposure to serum (lanes 1–3).
5-min exposure to serum (lanes 4–6).
(D) Phagocytosis assay showing
wild-type NTUH-K2044 is less asso-
ciated with mouse macrophages than
magA  mutant or cps  mutant. Com-
plementation with magA-carrying
plasmid partially restores the pheno-
type. (E and F) Fluorescence micros-
copy images (original magnification,
400). Wild-type NTUH-K2044 (E)
is less likely to be ingested or attached
by human neutrophils than a magA 
mutant (F). (G) Confocal fluores-
cence microscopy showing that
magA  mutants were ingested and
disintegrated by human neutrophils.Fang et al. 701
liver cirrhosis) and in 15 out of 52 noninvasive strains
(29%; Fig. 4, A and B). The difference in frequencies of
occurrence of the locus in the invasive versus noninvasive
strains was statistically significant (P   0.0001; Fisher’s ex-
act test). All of the five strains causing septic metastatic
complications were strongly positive. The 15 dot-blot pos-
itive noninvasive strains included 8 out of 9 HV  noninva-
sive strains. The invasive strain negative for string test was
also magA positive and highly serum resistant. We further
tested 21 nonblood isolates and 100 strains obtained outside
NTUH. The result showed that magA was positive in six
out of the eight invasive and abscess-causing strains (five
out of the six strains were collected at the National Cheng
Kung University Hospital, and one strain was collected at
the ECK Hospital). However, magA was found to be posi-
tive in only three isolates (1 of the 21 nonseptic isolates
from our hospital, 1 of the 15 Hong Kong strains, and
ATCC8045) of the remaining 113 strains that did not cause
apparent liver abscess. The correlation between the pres-
ence of magA and clinical tissue-invasive diseases remains
significant (P   0.0001; Fisher’s exact test). The results of
the dot-blot hybridizations were confirmed by PCR and
DNA sequencing (Fig. 4 C). The two tests correlated very
well, only one weakly positive dot (Fig. 4 A, dot 3G) was
proven to be magA negative by PCR and sequencing.
Characteristics of magA  Mutants. The growth curves of
magA  mutants were not significantly different from wild
type (not depicted). Under light microscopy with Periodic
Acid Schiff stain, wild-type NTUH-K2044 produced a
mucoviscous exopolysaccharide web attached to the cap-
sule (Fig. 1 B). The individual bacteria were intercon-
nected to each other by this web. In addition to a high re-
sistance to nonimmune human serum (Fig. 2 A), wild-type
bacteria were also highly resistant to phagocytosis by mac-
rophages (Fig. 2 D) or neutrophils (Fig. 2 E). The magA 
mutants remained encapsulated, but did not produce the
exopolysaccharide web (Fig. 1 C). magA  mutants were
extremely sensitive to nonimmune human serum, which
killed all of the mutants in 1 h (Fig. 2 A). After exposure to
serum, both the magA  and cps  mutants had a much
higher level of complement C3 deposition than wild-type
bacteria at 1 min (Fig. 2 C). The cells of mutant bacteria
began to degrade in 5 min. magA  mutants were also sus-
ceptible to phagocytosis. Phagocytosis assay using either
mouse macrophage (Fig. 2 D) or human neutrophil (Fig. 2
F) showed that the amount of intracellular and cell-associ-
ated magA  mutants was much higher than that of the wild
type. Confocal fluorescence microscopy confirmed that the
cell-associated magA  mutants were ingested and disinte-
grated by human neutrophils (Fig. 2 G). In contrast, the
Table I. Genetic Loci Associated with Hypermucoviscosity in K. pneumoniae
Mutant Loci Function Reference
1–11a cps cluster capsular polysaccharide synthesis 37
12 wb cluster lipopolysaccharide synthesis 38
13b novel 1.2-kb ORF identical to mutant 18 –
14 novel 1.6-kb ORF 57-kD hypothetical protein, putative thiosulfate sulfurtransferase –
15 novel 0.9-kb ORF 33-kD hypothetical protein –
16c –– –
17 cps cluster ORF 6 80-kD hypothetical protein, function unknown 37
18b novel 1.2-kb ORF 43-kD hypothetical protein, putative membrane lipoprotein –
19 novel 1.6-kb ORF 57-kD hypothetical protein, putative phosphotransferase –
20 rmpA extracapsular polysaccharide synthesis regulator 39, 40
aMutants 1–10, gross loss of mucoid phenotype. Mutants 11–20, negative string test.
bMutants 13 and 18, the same locus was disrupted.
cMutant 16, it possessed double insertion of transposon and was not further studied. 
ORF, open reading frame.
Figure 3. (A and B) Histopathology in the liver and brain of a mouse
inoculated with 105 CFU of K. pneumoniae NTUH-K2044, examined on
day 9 after inoculation (hematoxylin and eosin stain; original magnification,
200). (C and D) Histopathology in the liver and brain of a mouse inoculated
with 105 CFU of K. pneumoniae MGH-78578, examined on day 9 after
inoculation (hematoxylin and eosin stain; original magnification, 200).
A and B show severe meningitis and liver microabscess. C and D show
normal histology.magA Gene in K. pneumoniae Causing Liver Abscess 702
microscopy technique failed to detect intracellular wild-
type bacteria at any time point. Moreover, CFUs of the
wild-type strain in nonphagocyte-associated washout was
consistent with the noningestion of the bacteria. In the
mouse experiments, all BALB/cByl mice remained healthy
6 wk after inoculation of 102–107 CFU of the magA  mu-
tants. In mice that were killed 3 wk after inoculation of the
bacteria, there was no microscopic evidence of liver mi-
croabscess or meningitis. Thus, magA was essential for
NTUH-K2044 to cause invasive disease in vivo.
Complementation. Complementation using a magA-
containing plasmid restored the HV phenotype, strong se-
rum resistance (Fig. 2 B), and virulence in the mouse
model. The LD50 of magA complement strains to BALB/
cByl mice was reduced to 103 CFU. The successful com-
plementation excluded the possibility that mutations else-
where were responsible for the phenotype change of
magA  mutants.
Functional Study of MagA. The magA gene was 1.2 kb
in length and encodes a protein with 408 amino acids (Gen-
Bank/EMBL/DDBJ accession no. AB085741). Analysis us-
ing the Protein Basic Local Alignment Search Tool (http://
www.ncbi.nlm.nih.gov/BLAST) and the SWISS-PROT
database showed that MagA was related to WaaL and a class
of proteins involved in exopolysaccharide production. Anal-
ysis using the Simple Modular Architecture Research Tool
(http://smart.embl-heidelberg.de; reference 41) showed
that the predicted amino acid sequence of MagA started
with a signal peptide (amino acids 1–18) followed by nine
transmembrane domains (amino acids 44–63, 70–92, 107–
126, 135–152, 172–189, 209–231, 246–268, 334–353, and
363–382). Western blotting detected a 43-kD protein (the
predicted size of MagA) in the outer membrane fraction of
wild-type NTUH-K2044 but not in that of magA  mutants
(Fig. 5). Further bioinformatics analysis of motif function
using the Protein Families Database of Alignments and Hid-
den Markov Models (Pfam 7.1) (http://www.sanger.ac.uk/
Pfam; reference 42) suggested that amino acids 338–348
functioned as a prokaryotic membrane lipoprotein lipid at-
tachment site (lipobox). Deletion constructs were prepared
in a magA  mutant carrying the complementation plasmid.
Deletion of the 3  end up to amino acid 368 did not change
the phenotype. However, an inframe deletion of the 20
amino acids (amino acids 338–357) of the lipid attachment
site made the strain serum sensitive and resulted in the loss
of the HV phenotype. This result was consistent with the
identity of magA as a lipoprotein. Nevertheless, the lipobox
was not located in the signal peptide as in a traditional
prokaryotic lipoprotein.
Sequence of magA Flanking Regions. We sequenced the
nearby genomic region of magA, and found a 33-kb ge-
nomic segment (GenBank/EMBL/DDBJ accession no.
AB117611), which was absent in the complete genome
sequence of MGH-78578 (http://genome.wustl.edu/
projects/bacterial/?kpneumoniae1). The 5  flanking region
of this fragment was a truncated open reading frame
(ORF), whose amino acid sequence displayed 97% homol-
ogy to that of E. coli OrfX (43). The 3  flanking region of
this fragment was hisI, a phosphoribosyl-AMP cyclohydro-
genase gene involved in amino acid transport and metabo-
lism in K. pneumoniae (44). This 33-kb DNA fragment
contained 24 ORFs. magA was the fourth ORF from the
5  end. Bioinformatics analysis suggested that the other 23
Figure 4. Dot-blot hybridization of geno-
mic DNA extracted from 40 invasive strains
(lanes B–F) and 40 noninvasive strains (lanes
G–K). Dot A1 is NTUH-K2044 as the
positive control. Dot L1 is the PCR product
of cepA (reference 29) as the negative control.
(A) Hybridization with magA probe. All the
invasive strains shown here were positive.
The noninvasive strains at dots 3G, 3H, 4H,
6G, 6H, 7G, 7H, 7I, and 8H were positive.
(B) Hybridization with 23S rRNA gene
probe as internal positive control. (C) PCR
for  magA. (lane 1) Marker. (lanes 2–6) 5
positive strains. (lanes 7–11) 5 negative
strains. (D) PCR for 23S rRNA gene as
control.
Figure 5. Western blot of magA (lanes 1–7) and NlpB (lanes 8–10).
(lanes 1–4) Cytoplasmic membrane, outer membrane, total proteins, and
spheroplast of NTUH-K2044. (lanes 5–7) Cytoplasmic membrane, outer
membrane, and spheroplast proteins of a magA  mutant. (lanes 8–10)
Outer membrane, cytoplasmic membrane, and periplasmic proteins of
NTUH-K2044. (arrow) 43 kD. (arrowhead) 37 kD.Fang et al. 703
genes might function in exopolysaccharide biosynthesis ex-
port of the O-antigen of the lipopolysaccharides, glycosyla-
tion and other modification of cell envelope, and polysac-
charides synthesis and transport.
Discussion
This paper shows that magA is an important virulence
gene in invasive K. pneumoniae strains causing primary liver
abscess and septic metastatic complications. Disruption of
magA in NTUH-K2044 results in complete loss of resis-
tance to serum and phagocytosis, along with a  105-fold
increase in LD50 to mice. The virulence was significantly
but not completely restored by complementation using a
magA-containing plasmid, suggested that adjacent loci
might also be contributing to virulence. Although other
genetic loci, including the cps cluster (37), wb cluster (38),
and rmpA (39, 40) might also be involved in bacterial viru-
lence, only magA displayed a significantly higher prevalence
rate in invasive strains (98 vs. 29%; P   0.0001). Thus,
magA meets the criteria of molecular Koch’s postulates (45)
for a virulence gene associated with this type of invasive K.
pneumoniae disease. Thus, this locus can be used as a marker
for rapid molecular diagnosis.
In the present work, our data provided supports for the
hypothesis that MagA was an outer membrane protein es-
sential for the formation of a protective exopolysaccharide
web in invasive K. pneumoniae strains. Deletion construction
experiments suggested that amino acids 338–348 might
have a key role in MagA functionality; however, an indirect
role (such as altered protein stability) cannot be excluded. In
addition to magA, the 33-kb fragment contains genes in-
volved in exopolysaccharide biosynthesis, export of the
O-antigen of the lipopolysaccharides, glycosylation, and other
modifications of cell envelope, and polysaccharide synthesis
and transport. Further studies are needed to clarify the pre-
cise role of MagA in HV phenotype, and its interaction
with components of bacterial surface envelopes such as
exopolysaccharide, capsular polysaccharides, and lipopoly-
saccharides. Although the molecular details remain to be
explored, the presence of MagA appears to alter the physi-
cochemical properties of the bacterial surface such that serum
complements cannot easily reach the bacterial cell mem-
brane, and phagocytic ingestion also becomes more difficult.
Being highly resistant to both serum killing and phagocyto-
sis, these invasive enteric bacteria may reach the liver
through the portal vein and cause primary liver abscess. If
the invasion of K. pneumoniae cannot be contained within
the liver, septic metastatic complications, such as metastatic
meningitis or metastatic endophthalmitis, might occur. Our
preliminary in vitro adherence assay found no evidence of
adhesion between human hepatocyte-derived cell lines and
these invasive K. pneumoniae strains. Thus, the predominant
presentation of primary liver abscess in this disease may be
the result of its enteric port of entry, rather than any real af-
finity between K. pneumoniae and liver. But further investi-
gations are needed to make a definite conclusion.
The pathogenesis of bacterial diseases often involves both
bacterial virulence and host factors (45). In the case of pri-
mary  K. pneumoniae liver abscess, bacterial virulence is
likely to play a major role because approximately half of the
cases occur in otherwise healthy persons (4–10). In vitro
serum resistance assays and in vivo animal inoculation ex-
periments in the present work demonstrated the highly
significant difference in virulence between clinical strains,
and suggested a potential virulence of NTUH-K2044 to
healthy subjects. There was a strong correlation between
magA and clinical invasive diseases among tested clinical
strains, including isolates from NTUH and other hospitals/
sites outside Taiwan. Nevertheless, the host factors may still
be important in some cases. The only magA-negative strain
in the invasive strains group was isolated from the patient
with liver cirrhosis and hepatic failure. Because of the un-
usual host factor in this case, this strain might not be a true
invasive strain. The presence of magA in 29% of the strains
that did not cause liver abscess should not be a surprise be-
cause the formation of a liver abscess might require an in-
cubation time up to several days, as shown by the results of
animal inoculation experiments in the present work.
Prompt early antibiotic therapy could modify the clinical
course and prevent the formation of liver abscess in some
cases. Thus, these magA positive strains might not be truly
“noninvasive.” Because patients with K. pneumoniae men-
ingitis or endophthalmitis do not always have concomitant
liver abscess (11, 46), there could be other bacterial as well
as host and environmental factors involved. Further investi-
gation of the involved host, and microbial and environ-
mental factors is needed.
In the past two decades, primary K. pneumoniae liver ab-
scess and its septic metastatic complications have emerged
as one of the most common community-acquired bacterial
diseases in Taiwan (4–12). Due to an increase in cases of
metastatic K. pneumoniae meningitis secondary to primary
liver abscess, K. pneumoniae has replaced Streptococcus pneu-
moniae as the leading pathogen of adult community-
acquired bacterial meningitis in Taiwan (11, 47, 48). During
this relatively short period, public sanitation in Taiwan has
continued to improve, and there has been no major change
in the population structure. The reason for this rapid in-
crease of primary K. pneumoniae liver abscess remains un-
clear. One possible contributing factor is the documented
overuse of amoxicillin and ampicillin in both agriculture
and medical practice in Taiwan in the past 20 yr (49). K.
pneumoniae is constitutively resistant to these two antibiotics
(1, 2, 10). Their overuse will eliminate susceptible micro-
organisms and encourage the colonization of K. pneumoniae
in both humans and animals. It is unknown whether this
type of invasive K. pneumoniae strain has a survival advan-
tage under antibiotic pressure, or whether they simply ac-
quire their unique virulence genes from other bacteria.
Identification of the virulence gene in K. pneumoniae strains
causing primary liver abscess and septic metastatic compli-
cations will be helpful in tracing the origins of this emerg-
ing infectious disease.magA Gene in K. pneumoniae Causing Liver Abscess 704
In conclusion, magA meets the molecular Koch’s postu-
lates of a virulence gene for invasive K. pneumoniae strains
causing primary liver abscess and septic metastatic compli-
cations. The gene is essential for invasive K. pneumoniae
strains to demonstrate an extraordinarily high resistance to
human serum and phagocytosis killing. This gene can be
used as a marker for rapid molecular diagnosis, and might
be also helpful in tracing the origins of this emerging infec-
tious disease. The MagA protein could also become a good
candidate for new drug targets in the future.
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